Learn more about the last weeks‘ top stories, upcoming events and funding opportunities in our 06-2015 e-newsletter edition. This time we feature for example AFFiRiS’ new financing round, the new team of Vice Rectors at the Medical University of Vienna, Scarletred acquiring a phase II product from Apeiron and Valneva taking direct control over marketing and distribution of IXIARO®.
Register here to stay updated on a regular base. Our e-newsletter is published 10 times a year.